Trial scope and risk acknowledgement
These provisions apply to a service identified in its specific disclosure as an authorized trial, within its permitted activities, duration and participant categories. This policy does not establish that a permit has been issued or covers every Rabeh service. Before participation, disclose the responsible entity, permit status and scope, monetary limits, exit terms and the entities handling funds and assets.
Participation acknowledgement: “I have reviewed the product disclosure and trial limits. I understand the risks of disruption, delay, partial or total loss and unavailable exit liquidity. A trial permit is not an investment recommendation or guarantee of capital or returns. My acknowledgement does not waive statutory rights or mandatory provider responsibilities.” Record this acknowledgement separately before participation; reading this page is not acceptance.
Protecting funds and records
Before accepting real trial funds, identify the money flow and each receiving, holding or settling entity and verify its legal authority. Segregate client funds from operating funds where the activity and law require it, with documented reconciliation against the custodian or payment provider. One client's funds must not cover another client's shortfall or operating costs.
The product disclosure must explain repayment of uninvested money and the position of amounts committed to assets or contracts that cannot be liquidated immediately. This policy does not establish insurance, a compensation fund or a government guarantee.
Trial limits and stopping expansion
Real-money trials must not start before approval of aggregate exposure, per-participant and per-transaction limits, participant count, product scope and trial duration. Disclose applicable limits before commitment and obtain required approvals before increases.
The containment plan requires server-side enforcement and controls against splitting transactions, separation of trial access and data, and suspension of new operations or participants when limits are reached, reconciliation fails or a material defect emerges. These measures aim to restrict harm; they do not guarantee no wider market impact.
Incident response and orderly exit
Escalate material defects to the incident lead and compliance, isolate affected functions, suspend operations that could increase harm, preserve evidence and prevent unverified financial re-execution. Identify affected clients, transactions and balances and communicate effects on rights and safe support channels.
If safe recovery is not possible, the trial ends or permission is withdrawn, stop new commitments, reconcile entitlements, settle pending operations and return amounts due through verified channels, or transfer to an authorized provider where lawful with required procedures. Maintain complaints access, retain legally required records and dispose of the rest under the retention policy. Resume affected activity only after verified remediation and required approvals.
Claims, compensation and settlement
Submit claims through the contact page or published email with a transaction reference and description of harm, never a password or verification code. Record a tracking reference, preserve evidence, assess cause, loss and causation, and provide a reasoned outcome and objection route.
Correct erroneous entries, repay amounts due and address compensation under established liability, law, contract or competent authority decisions. Do not use other clients' funds or condition repayment of undisputed amounts on waiving complaints rights. Market loss alone is not an operational failure, and mandatory liability for negligence is not excluded. Settlement must preserve non-waivable rights.
Potential benefits and investor protection measures
The trial targets clearer disclosure, traceable entitlements, fewer processing errors and shorter service times. Compare benefits against documented baselines using completion time, service cost, reconciliation errors, complaints and resolution, and participants' understanding of risk. Assess losses and incidents alongside benefits and stop expansion if protection criteria fail. These are intended benefits, not guaranteed returns.